Dopaquinone and related compounds: reactions with o phenylenediamine

DOI: 10.1246/bcsj.47.1957

Source and publish data:

Bulletin of the Chemical Society of Japan p. 1957 - 1959 (1974)

Update date:2022-07-29

Topics:

Authors:

Omote Omote

Hirama Hirama

Komatsu Komatsu

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1246/bcsj.47.1957

Full text of DOI:10.1246/bcsj.47.1957

Products guided by the article

Product name:2-benzoylamino-3-phenazin-2-yl-propionic acid methyl ester

Cas No:54296-22-9

R&D Labs maybe for 54296-22-9

EnBridge PharmTech Co., Ltd.

website:http://www.enbridgepharm.com

Contact:+86-510-83591909

Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China
zhuzhou zhongle chemical co. ltd.

Contact:+86-0731 28228409

Address:Zhuzhou, Hunan, China
Shanghai doly chemical Co.,Ltd

Contact:+86-21-34716221

Address:No.328,WuHe Roard,MinHang,ShangHai China
JIANGXI ZHANGFENG CHEMICAL CO., LTD.

Contact:+86-0799-3413066

Address:Xiyuan village, Xiabu Town, Xiangdong District
Shanghai Egoal Chemical Co.,Ltd

Contact:+86-21-50333091

Address:Yangming Garden Square 3,YangGao North Road 1188, Pudong New District, Shanghai

Relevant to this article

Scouting human A₃ adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study

Doi:10.1021/jm070852a
(2007)
Unexpected tosyl deprotection during osmium catalysed dihydroxylation

Doi:10.1016/j.tetlet.2007.11.058
(2008)
Syntheses, structures and redox properties of some complexes containing the Os(dppe)Cp* fragment, including [{Os(dppe)Cp*}₂(μ- CCCC)]

Doi:10.1039/b712104k
(2007)
Strong inhibition of cholera toxin binding by galactose dendrimers

Doi:10.1039/b711070g
(2007)
Blue emitters based on Anthracene-Aryl-Anthracene moieties end-capped with 1-naphthyl groups for organic light-emitting diodes

Doi:10.1166/jnn.2015.10392
(2015)
Application of spectrophotometric, densitometric, and HPLC techniques as stability indicating methods for determination of Zaleplon in pharmaceutical preparations

Doi:10.1016/j.saa.2007.01.024
(2007)

Article Doi